Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

Nyxoah announced the first patient implantation in BREATHE, a U.S. post-approval study of its Genio system for obstructive sleep apnea treatment. The multicenter study will implant up to 229 patients across 25 U.S. centers and follow them for up to five years to evaluate long-term safety and effectiveness of the bilateral hypoglossal nerve stimulation therapy in real-world clinical practice.